The daily business briefing: December 1, 2021
Powell says the Fed is considering tapering bond purchases sooner, FDA advisers recommend approving Merck COVID treatment, and more
- 1. Jerome Powell says Fed considering speeding up taper stimulus efforts
- 2. FDA panel narrowly recommends Merck COVID treatment
- 3. Thanksgiving weekend shopping traffic falls slightly
- 4. U.S. moving to impose tighter COVID testing requirements on travelers
- 5. Stock futures rise as volatility continues
1. Jerome Powell says Fed considering speeding up taper stimulus efforts
Federal Reserve Chair Jerome Powell told members of the Senate Banking Committee on Tuesday that the central bank might speed up plans to taper its bond-buying program, which is boosting the economic recovery, as it tries to counter accelerating inflation. The remarks came as the Fed tries to contend with both a strong recovery that is driving up prices for food and shelter, and the threat that another virus surge fueled by the newly discovered Omicron variant could prevent millions of people from returning to work and prevent disrupted supply chains from unclogging. Powell said it was too soon for anyone to know how the new coronavirus variant will damage the economy. He said it will take about a month to answer many questions, but "we'll know something … within a week or 10 days."
2. FDA panel narrowly recommends Merck COVID treatment
A Food and Drug Administration advisory committee voted Tuesday to recommend authorization of Merck's antiviral pill to fight severe COVID-19. The unexpectedly narrow 13-to-10 vote reflected concerns about the drug's limited effectiveness and possible reproductive harm. The FDA is not obligated to follow the recommendations of the panel of outside experts, who backed authorizing the pill for patients at high risk of severe illness. If regulators authorize the drug's use, it could be available to patients within weeks, as public health officials rush to prepare for the spread of the newly discovered Omicron variant of the coronavirus. In the coming weeks, the FDA will decide whether to authorize a similar pill developed by Pfizer that is believed to be more effective.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
3. Thanksgiving weekend shopping traffic falls slightly
About 180 million Americans shopped in stores or online between Thanksgiving and Cyber Monday, down from 186 million last year and 190 million in 2019, the National Retail Federation said Tuesday. One reason for the decline was that many people started their holiday shopping early to avoid missing out on popular items due to supply disruptions caused by the coronavirus pandemic. Many shoppers were lured out as early as October by retailers that launched holiday promotions early. Retail analysts said it was too early to tell whether the Omicron strain of the coronavirus would affect the holiday shopping season. South Africa announced the detection of the fast-spreading new variant just before Black Friday.
4. U.S. moving to impose tighter COVID testing requirements on travelers
The U.S. is preparing to tighten coronavirus testing requirements for all air travelers entering the country as part of the Biden administration's response to the new Omicron coronavirus variant, the Centers for Disease Control and Prevention said Tuesday. Currently, vaccinated air travelers need to show a negative COVID test administered within three days of departure toward the U.S., while unvaccinated travelers must show a negative test within one day of arrival. Under a new rule expected to be announced by President Biden as soon as Thursday, all travelers, including U.S. citizens, will be required to show a negative test performed within one day of departure. Nearly all foreign nationals currently have to show that they have been fully vaccinated to enter the United States.
5. Stock futures rise as volatility continues
U.S. stock index futures rose early Wednesday as markets remained volatile due to the emergence of the new Omicron coronavirus variant. Futures tied to the S&P 500 and the Dow Jones Industrial Average were up by 1.1 percent and 0.8 percent, respectively. Futures for the Nasdaq gained 1.3 percent. The three main U.S. indexes fell sharply on Tuesday, after rebounding Monday from Friday's steep losses. The turmoil began after South Africa reported the existence of the new virus. It has since been detected in 20 countries. Gregory Daco, chief U.S. economist at Oxford Economics, said "markets appear to be having trouble digesting" uncertainty over the Omicron variant and the rising likelihood the Federal Reserve will fight high inflation by unwinding its economy-boosting policies more quickly.
Create an account with the same email registered to your subscription to unlock access.
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Harold Maass is a contributing editor at The Week. He has been writing for The Week since the 2001 debut of the U.S. print edition and served as editor of TheWeek.com when it launched in 2008. Harold started his career as a newspaper reporter in South Florida and Haiti. He has previously worked for a variety of news outlets, including The Miami Herald, ABC News and Fox News, and for several years wrote a daily roundup of financial news for The Week and Yahoo Finance.
-
Ottawa climate talks: can global plastic problem be solved?
In the spotlight Nations aim to draft world's first treaty on plastic pollution, but resistance from oil- and gas-producing countries could limit scope
By Harriet Marsden, The Week UK Published
-
Netherlands split on WFH for sex workers
Speed Read Councils concerned over 'nuisance' of at-home sex work, but others say changes will curb underground sex trade
By Arion McNicoll, The Week UK Published
-
'He adored Trump, and then rejected him'
Today's Newspapers A roundup of the headlines from the US front pages
By The Week Staff Published
-
Why is Tesla stumbling?
In the Spotlight More competition, confusion about the future and a giant pay package for Elon Musk
By Joel Mathis, The Week US Published
-
The wine industry is getting pressed as young people drink less
Under the Radar The once-dominating drink is not aging well
By Anya Jaremko-Greenwold, The Week US Published
-
The largest insurance company payouts
In The Spotlight Fights over insurance have been in the spotlight following the collapse of the Francis Scott Key Bridge in Baltimore
By Justin Klawans, The Week US Published
-
Disney board fends off Peltz infiltration bid
Speed Read Disney CEO Bob Iger has defeated activist investor Nelson Peltz in a contentious proxy battle
By Rafi Schwartz, The Week US Published
-
Visa and Mastercard agree to lower swipe fees
Speed Read The companies will cap the fees they charge businesses when customers use their credit cards
By Peter Weber, The Week US Published
-
Reddit IPO values social media site at $6.4 billion
Speed Read The company makes its public debut on the New York Stock Exchange
By Peter Weber, The Week US Published
-
Disney is engaged in a proxy battle against activist investors
Under the Radar Members of the Disney family are backing the company's leadership in the fight
By Justin Klawans, The Week US Published
-
Chinese electric cars may be coming to spy on you
Talking Points The Biden administration investigates Chinese electric cars as a potential economic and national security threat
By Harold Maass, The Week US Published